Skip to main content
Clinical Trials/NL-OMON32909
NL-OMON32909
Completed
Not Applicable

11C-MET PET(/CT) vs 18F-FDG PET(/CT) in the follow-up of differentiated thyroid cancer* - 11C-MET PET(/CT) in DTC

niversitair Medisch Centrum Groningen0 sites40 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
niversitair Medisch Centrum Groningen
Enrollment
40
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • \- \> 18 years old
  • \- Total thyroidectomy
  • \- Negative post\-treatment 131I\-WBS with elevated Tg(on) (\>5\.0 ng/ml)
  • \- Signed informed consent ;Study 2
  • \- \> 18 years old
  • \- Total thyroidectomy
  • \- Patients with persistent or recurrent Hürthlecell carcinoma in post\-ablation phase or during follow\-up
  • \- Signed informed consent

Exclusion Criteria

  • Both studies:
  • \- Pregnancy
  • \- Patients with any signs of neurological or psychiatric disorders that will preclude him/her from expressing her/his own free will

Outcomes

Primary Outcomes

Not specified

Similar Trials